Actively Recruiting
A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
Led by Ono Pharmaceutical Co., Ltd. · Updated on 2025-06-03
108
Participants Needed
14
Research Sites
291 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
CONDITIONS
Official Title
A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed by pathology with one of these types of lymphoid cancers: Peripheral T-cell lymphoma (including angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma NOS, nodal PTCL with TFH phenotype), follicular T-cell lymphoma, cutaneous T-cell lymphoma (mycosis fungoides, Sezary syndrome), or chronic lymphocytic leukemia/small lymphocytic lymphoma
- Patients with relapsed or refractory tumors lacking standard therapy options, or who cannot tolerate existing standard treatments as judged by investigators
- ECOG performance status of 0 to 2
- Life expectancy of at least 3 months
You will not qualify if you...
- Patients with severe complications
- Patients with multiple cancers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 14 locations
1
Aichi Cancer Center Hospital
Nagoya, Aichi-ken, Japan
Actively Recruiting
2
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
Actively Recruiting
3
Akita University Hospital
Akita, Akita, Japan
Actively Recruiting
4
National Cancer Center Hospital East
Kashiwa-shi, Chiba, Japan
Actively Recruiting
5
Kyushu University Hospital
Fukuoka, Fukuoka, Japan
Actively Recruiting
6
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Actively Recruiting
7
Tokai University Hospital
Isehara-shi, Kanagawa, Japan
Actively Recruiting
8
Kumamoto University Hospital
Kumamoto, Kumamoto, Japan
Actively Recruiting
9
University Hospital Kyoto Prefectural University of Medicine
Kyoto, Kyoto, Japan
Actively Recruiting
10
Tohoku University Hospital
Sendai, Miyagi, Japan
Actively Recruiting
11
Okayama University Hospital
Okayama, Okayama-ken, Japan
Actively Recruiting
12
Kindai University Hospital
Osaka Sayama-shi, Osaka, Japan
Actively Recruiting
13
Osaka University Hospital
Osaka-fu, Osaka, Japan
Not Yet Recruiting
14
Cancer Institute Hospital of JFCR
Koto-ku, Tokyo, Japan
Actively Recruiting
Research Team
N
North America Clinical Trial Support Desk
CONTACT
I
International Clinical Trial Support Desk
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here